We are live on
!
Find out more
CWM
CIBC World Markets Portfolio holdings
AUM
$20.8B
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$4.36B
(-26%)
Cap. Flow
-$3.8B
Cap. Flow
% of AUM
-29.89%
Top 10 Holdings %
Top 10 Hldgs %
38.21%
Holding
1,893
New
568
Increased
757
Reduced
513
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$211M |
| 2 |
Crown Castle
CCI
|
+$52.2M |
| 3 |
Tesla
TSLA
|
+$46.6M |
| 4 |
XP
XP
|
+$25.2M |
| 5 |
EA
Electronic Arts
EA
|
+$22.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$587M |
| 2 |
Honeywell
HON
|
+$142M |
| 3 |
Mastercard
MA
|
+$126M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Financials | 11.86% |
| 3 | Consumer Discretionary | 10.19% |
| 4 | Communication Services | 9.97% |
| 5 | Healthcare | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Invivyd
IVVD
$194M
| $10.7K | ﹤0.01% |
+17,598
| New | +$15.8K |
|
|
APLT
1827
DELISTED
Applied Therapeutics
APLT
| $10.6K | ﹤0.01% |
+21,728
| New | +$12.8K |
|
1828
Purple Innovation
PRPL
$39.3M
| $9.58K | ﹤0.01% |
+505
| New | +$11.6K |
|
1829
Nautilus Biotechnolgy
NAUT
$113M
| $9.31K | ﹤0.01% |
+10,811
| New | +$16.1K |
|
|
NOVA
1830
DELISTED
Sunnova Energy
NOVA
| $8.96K | ﹤0.01% |
24,100
+13,936
| +137% | +$26.8K |
|
1831
X4 Pharmaceuticals
XFOR
$393M
| $8.95K | ﹤0.01% |
1,262
+738
| +141% | +$10.2K |
|
|
TPIC
1832
DELISTED
TPI Composites
TPIC
| $8.25K | ﹤0.01% |
+10,231
| New | +$13.4K |
|
|
MRSN
1833
DELISTED
Mersana Therapeutics
MRSN
| $8.19K | ﹤0.01% |
952
+527
| +124% | +$8.13K |
|
1834
Tenaya Therapeutics
TNYA
$163M
| $6.98K | ﹤0.01% |
+12,239
| New | +$12.1K |
|
1835
LanzaTech
LNZA
$68M
| $6.01K | ﹤0.01% |
248
+143
| +136% | +$12.9K |
|
1836
Century Therapeutics
IPSC
$343M
| $4.94K | ﹤0.01% |
+10,384
| New | +$7.8K |
|
1837
374Water
SCWO
$39M
| $4.93K | ﹤0.01% |
+1,450
| New | +$6.41K |
|
|
GBIO
1838
DELISTED
Generation Bio
GBIO
| $4.45K | ﹤0.01% |
+1,098
| New | +$7.71K |
|
1839
Ovid Therapeutics
OVID
$495M
| $4.08K | ﹤0.01% |
+13,068
| New | +$8.04K |
|
|
ELEV
1840
DELISTED
Elevation Oncology
ELEV
| $3.25K | ﹤0.01% |
+12,523
| New | +$7.15K |
|
|
LYRA
1841
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $1.36K | ﹤0.01% |
+215
| New | +$2.01K |
|
|
STI
1842
DELISTED
SunTrust Banks, Inc.
STI
| $1.33K | ﹤0.01% |
+11,042
| New | +$1.33K |
|
1843
CALL
Alcoa
AA
$12.5B
| – | – |
-11,052
| Closed | -$418K |
|
1844
Alerian MLP ETF
AMLP
$12.9B
| – | – |
-86,056
| Closed | -$4.14M |
|
|
APLS
1845
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-1,285,300
| Closed | -$41M |
|
1846
Arm
ARM
$306B
| – | – |
-2,838
| Closed | -$350K |
|
1847
ASML
ASML
$655B
| – | – |
-1,965
| Closed | -$1.36M |
|
1848
AngloGold Ashanti
AU
$44.3B
| – | – |
-15,000
| Closed | -$346K |
|
1849
AstraZeneca
AZN
$250B
| – | – |
-6,451
| Closed | -$845K |
|
1850
Alibaba
BABA
$304B
| – | – |
-24,730
| Closed | -$2.1M |
|
Similar funds
VRS
FAF
BGIM
CIM
PPFA
UOC
FNBT
CIBC World Markets's Q1 2025 Portfolio in Review
As of Q1 2025, CIBC World Markets held 1,893 positions worth $12.7B, down 26% from $17.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
CIBC World Markets withdrew a net $3.8B in Q1 2025, closing 51 positions and reducing 513 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, CIBC World Markets opened a new position in XP worth $25.2M.
- CIBC World Markets's largest Q1 2025 buy was XP: 1,832,600 shares worth $25.2M.
- CIBC World Markets added most to Microsoft in Q1 2025, an estimated $211M increase.
- CIBC World Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $587M.
- CIBC World Markets fully exited Apellis Pharmaceuticals in Q1 2025, selling an estimated $41M.
- CIBC World Markets's ten largest holdings make up 38% of its $12.7B portfolio in Q1 2025.
- CIBC World Markets opened 568 new positions and closed 51 in Q1 2025.
- CIBC World Markets's portfolio value fell 26% quarter-over-quarter to $12.7B.
Based on CIBC World Markets's 13F filing for Q1 2025, filed 13 May 2025.